US clinical-stage US autoimmune drug developer Kyverna Therapeutics saw its shares leap more than 23% to $10.82 after its ...

Reuters Events’ flagship European cross-functional meeting for pharma leaders shaping the industry’s commercial and ...

Dren Bio, a privately held, US clinical-stage biotechnology company developing first-in-class myeloid cell engager ...

US biotech Immunome has announced positive top-line results from the global pivotal Phase III RINGSIDE trial of varegacestat, ...

South Korea-based Lunit, a provider of AI for cancer diagnostics and precision oncology, has announced a deal with Japanese ...

UK based liquid medicines maker Rosemont Pharmaceuticals has appointed an American chief executive (CEO) as the business ...

UK-based Bicycle Therapeutics, a pharma company developing a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, has entered into a 15-year ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the USA ...

The US Food and Drug Administration (FDA) yesterday removed a key limitation on the use of real-world evidence (RWE) used in ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved pharma major GSK’s Exdensur (depemokimab), the first twice-yearly biological medicine for use as an add-on treatment for ...

UK pharma major AstraZeneca today revealed that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...

Link Cell Therapies, an oncology cell therapy company, has announced its official launch from stealth with a $60 million ...